Atlas Trials

Chronic Hepatitis C Genotype-1 Relapse

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Hepatitis C Genotype-1 Relapse

RecordFirmDate
Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients (NCT00983060)Novartis Pharmaceuticals2009-09-01

Track Chronic Hepatitis C Genotype-1 Relapse automatically

Every clearance here is in the API, with alerts when new ones post.